Robert L. van Nostrand, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 10,000 shares at $63.00 ($630K) on 2023-04-17, disclosed to the SEC on 2023-04-19.
Scheduled sale ($630k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ITCI | SELL | 2024-02-28 | $2.9M | — | Filing → |
| ITCI | SELL | 2022-08-12 | $1.7M | — | Filing → |
| MBLX | BUY | 2012-12-04 | $21K | — | Filing → |